搜尋
Evolus Inc
EOLS添加自選
5.840USD
-0.170-2.83%
收盤 07-31 16:00（美東）報價延遲15分鐘
384.59M總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Lynch (Timothy Patrick)
9.76%
Nantahala Capital Management, LLC
8.84%
BlackRock Institutional Trust Company, N.A.
5.62%
Braidwell LP
4.72%
Frazier Life Sciences Management, L.P.
3.99%
其他
67.07%
持股股東
持股股東
佔比
Lynch (Timothy Patrick)
9.76%
Nantahala Capital Management, LLC
8.84%
BlackRock Institutional Trust Company, N.A.
5.62%
Braidwell LP
4.72%
Frazier Life Sciences Management, L.P.
3.99%
其他
67.07%
股東類型
持股股東
佔比
Hedge Fund
32.26%
Investment Advisor
19.57%
Investment Advisor/Hedge Fund
15.65%
Individual Investor
11.44%
Private Equity
3.99%
Research Firm
3.79%
Corporation
3.24%
Insurance Company
0.20%
Pension Fund
0.15%
其他
9.70%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
391
50.03M
75.98%
-16.02M
2025Q4
356
58.38M
89.22%
--
2025Q3
366
58.59M
90.20%
-409.50K
2025Q2
368
58.97M
91.09%
+3.93M
2025Q1
354
55.05M
88.70%
-1.35M
2024Q4
343
52.59M
87.55%
+1.63M
2024Q3
334
50.95M
89.20%
-1.08M
2024Q2
328
52.17M
86.99%
+2.08M
2024Q1
314
50.10M
82.52%
-553.42K
2023Q4
296
45.99M
83.45%
+2.48M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Lynch (Timothy Patrick)
6.43M
9.88%
+1.29M
+25.17%
Dec 31, 2025
Nantahala Capital Management, LLC
5.82M
8.95%
+93.79K
+1.64%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.70M
5.69%
-285.94K
-7.17%
Dec 31, 2025
Braidwell LP
3.11M
4.77%
+3.11M
--
Dec 31, 2025
Frazier Life Sciences Management, L.P.
2.63M
4.04%
--
--
Dec 31, 2025
Medy Tox Inc
2.14M
3.28%
-1.24M
-36.82%
Dec 31, 2024
Millennium Management LLC
2.09M
3.22%
+234.03K
+12.59%
Dec 31, 2025
Stonepine Capital Management, LLC
1.63M
2.51%
+95.20K
+6.20%
Dec 31, 2025
State Street Investment Management (US)
1.57M
2.42%
+59.63K
+3.94%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
State Street SPDR S&P Pharmaceuticals ETF
0.97%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.93%
iShares U.S. Pharmaceuticals ETF
0.15%
iShares Micro-Cap ETF
0.07%
ProShares Ultra Nasdaq Biotechnology
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
Schwab U.S. Small-Cap ETF
0.01%
查看更多
State Street SPDR S&P Pharmaceuticals ETF
佔比0.97%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比0.93%
iShares U.S. Pharmaceuticals ETF
佔比0.15%
iShares Micro-Cap ETF
佔比0.07%
ProShares Ultra Nasdaq Biotechnology
佔比0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.06%
Invesco Nasdaq Biotechnology ETF
佔比0.04%
ProShares Hedge Replication ETF
佔比0.02%
iShares Russell 2000 Growth ETF
佔比0.02%
Schwab U.S. Small-Cap ETF
佔比0.01%